The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2.

Watts, Norman R; Eren, Elif; Palmer, Ira; Huang, Paul L; Huang, Philip Lin; Shoemaker, Robert H; Lee-Huang, Sylvia; Wingfield, Paul T

Watts, Norman R; Eren, Elif; Palmer, Ira; Huang, Paul L; Huang, Philip Lin; Shoemaker, Robert H; Lee-Huang, Sylvia; Wingfield, Paul T.

Affiliation

Watts NR; Protein Expression Laboratory, NIAMS, NIH, Bethesda, Maryland, United States of America.
Eren E; Protein Expression Laboratory, NIAMS, NIH, Bethesda, Maryland, United States of America.
Palmer I; Protein Expression Laboratory, NIAMS, NIH, Bethesda, Maryland, United States of America.
Huang PL; Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Huang PL; Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, NCI, NIH, Bethesda, Maryland, United States of America.
Lee-Huang S; Department of Biochemistry and Molecular Pharmacology, New York University, Grossman School of Medicine, New York, New York, United States of America.
Wingfield PT; Protein Expression Laboratory, NIAMS, NIH, Bethesda, Maryland, United States of America.

PLoS One ; 18(6): e0286370, 2023.

Article de En | MEDLINE | ID: mdl-37384752

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Séropositivité VIH / Momordica charantia / COVID-19 Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google